These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23352629)

  • 1. Association of metformin use with cancer incidence and mortality: a meta-analysis.
    Zhang P; Li H; Tan X; Chen L; Wang S
    Cancer Epidemiol; 2013 Jun; 37(3):207-18. PubMed ID: 23352629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
    Raval AD; Thakker D; Vyas A; Salkini M; Madhavan S; Sambamoorthi U
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):110-21. PubMed ID: 25667109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.
    Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F
    Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
    Zhang H; Gao C; Fang L; Zhao HC; Yao SK
    Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer.
    Spillane S; Bennett K; Sharp L; Barron TI
    Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1364-73. PubMed ID: 23753040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of metformin on mortality following cancer among patients with diabetes.
    Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis on the association between bladder cancer and occupation.
    Reulen RC; Kellen E; Buntinx F; Brinkman M; Zeegers MP
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):64-78. PubMed ID: 18815919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.
    Gandini S; Puntoni M; Heckman-Stoddard BM; Dunn BK; Ford L; DeCensi A; Szabo E
    Cancer Prev Res (Phila); 2014 Sep; 7(9):867-85. PubMed ID: 24985407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
    Decensi A; Puntoni M; Goodwin P; Cazzaniga M; Gennari A; Bonanni B; Gandini S
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1451-61. PubMed ID: 20947488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
    Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
    Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus.
    Salpeter SR; Buckley NS; Kahn JA; Salpeter EE
    Am J Med; 2008 Feb; 121(2):149-157.e2. PubMed ID: 18261504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis.
    Fon Sing M; Yang WS; Gao S; Gao J; Xiang YB
    Eur J Cancer Prev; 2011 May; 20(3):157-65. PubMed ID: 21403523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
    He XK; Su TT; Si JM; Sun LM
    Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of metformin in polycystic ovary syndrome: a meta-analysis.
    Creanga AA; Bradley HM; McCormick C; Witkop CT
    Obstet Gynecol; 2008 Apr; 111(4):959-68. PubMed ID: 18378757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
    Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
    Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
    Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
    [No Abstract]   [Full Text] [Related]  

  • 18. Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis.
    Zhang M; He JQ
    Eur J Clin Pharmacol; 2020 Feb; 76(2):149-159. PubMed ID: 31786617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-Analysis.
    Yang T; Yang Y; Liu S
    J Breast Cancer; 2015 Sep; 18(3):264-70. PubMed ID: 26472977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.
    Onishi A; Sugiyama D; Kumagai S; Morinobu A
    Arthritis Rheum; 2013 Jul; 65(7):1913-21. PubMed ID: 23576072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.